Bladder cancer is a significant health concern, and understanding its diagnosis, treatment options, and the importance of urology care is crucial for patients and their families. This article provides a comprehensive overview of bladder cancer, addressing frequently asked questions and detailing the diagnostic and treatment pathways available.
Understanding Bladder Cancer Diagnosis
Accurate diagnosis is the first step in effectively managing bladder cancer. Several tests and procedures are employed to detect and characterize this condition, ensuring that patients receive the most appropriate and timely care.
Cystoscopy
Cystoscopy is a primary diagnostic procedure that allows urologists to directly visualize the inside of the bladder and urethra. This procedure involves inserting a thin, flexible tube with a camera (cystoscope) through the urethra into the bladder. Cystoscopy can be performed in both men and women to identify abnormalities such as tumors, stones, or inflammation.
Female Cystoscopy
Female cystoscopy is a vital diagnostic tool in urology. It enables healthcare providers to examine the female lower urinary tract, including the bladder, for conditions like bladder cancer, stones, and other abnormalities. Surgical instruments can be passed through the cystoscope for biopsies or treatments during the procedure.
Male Cystoscopy
Male cystoscopy allows detailed examination of the male urethra and bladder, crucial for diagnosing bladder cancer and other urological issues. This procedure helps in visualizing any blockages, tumors, or irregularities. Like female cystoscopy, it also permits the use of surgical tools for sample collection or treatment during the examination.
Biopsy (Transurethral Resection of Bladder Tumor – TURBT)
If any suspicious areas are identified during cystoscopy, a biopsy is typically performed. This involves removing a tissue sample for microscopic examination to determine if cancer cells are present. In the case of bladder cancer, a common procedure is Transurethral Resection of Bladder Tumor (TURBT). TURBT is performed during cystoscopy, where special instruments are used to remove the tumor and obtain a tissue sample. Importantly, TURBT is not only a diagnostic tool but can also be the initial treatment for bladder cancer that is confined to the bladder lining.
Urine Cytology
Urine cytology is a laboratory test that examines a urine sample under a microscope to detect cancerous cells. This non-invasive test can sometimes help identify bladder cancer, especially higher-grade tumors that shed cells into the urine. While urine cytology is less sensitive than cystoscopy for detecting early-stage bladder cancer, it can be a useful adjunct in the diagnostic process.
Imaging Tests
Imaging tests play a crucial role in visualizing the urinary tract and assessing the extent of bladder cancer.
-
CT Urogram: A CT urogram is a specialized CT scan that uses contrast dye to create detailed images of the kidneys, ureters, and bladder. This test helps to identify tumors in the urinary tract and is valuable for staging bladder cancer.
-
Retrograde Pyelogram: A retrograde pyelogram is an X-ray of the upper urinary tract. Contrast dye is injected directly into the ureters via a catheter inserted through the urethra and bladder. This procedure provides detailed images of the ureters and kidneys, which can be helpful in certain situations.
Determining the Extent and Grade of Bladder Cancer
Once bladder cancer is diagnosed, determining its extent (stage) and grade is essential for guiding treatment decisions and providing accurate prognosis.
Staging of Bladder Cancer
Staging determines if and how far the cancer has spread. This typically involves further imaging tests such as:
- CT Scan: To assess for spread to lymph nodes and distant organs.
- MRI (Magnetic Resonance Imaging): Provides detailed images of soft tissues, useful for local staging and assessing muscle invasion.
- PET (Positron Emission Tomography) Scan: May be used in certain cases to detect distant metastases.
- Bone Scan: If bone metastasis is suspected.
- Chest X-ray: To check for lung metastasis.
The stage of bladder cancer is classified using Roman numerals from 0 to IV, with higher stages indicating more advanced disease. Stage 0 and stage I indicate early-stage cancer confined to the inner layers of the bladder, while stage IV denotes cancer that has spread to distant sites.
Grading of Bladder Cancer
The grade of bladder cancer refers to how abnormal the cancer cells appear under a microscope. Grading helps predict the behavior of the cancer.
-
Low-grade bladder cancer: Cells are well-differentiated, resembling normal cells. Low-grade tumors tend to grow slowly and are less likely to invade the muscle layer of the bladder.
-
High-grade bladder cancer: Cells are poorly differentiated, appearing very abnormal and disorganized. High-grade tumors are more aggressive, grow faster, and have a higher risk of muscle invasion and spread.
Bladder Cancer Treatment and Urology Care Options
Treatment for bladder cancer is highly individualized and depends on several factors, including the stage and grade of the cancer, the patient’s overall health, and their preferences. Urology care encompasses a range of treatment modalities, ensuring a comprehensive approach to managing this disease.
Surgery
Surgical interventions are often the cornerstone of bladder cancer treatment.
-
Transurethral Resection of Bladder Tumor (TURBT): As mentioned earlier, TURBT is used for both diagnosis and treatment of non-muscle-invasive bladder cancer. It removes tumors from the bladder lining without requiring external incisions. Post-TURBT, intravesical chemotherapy or immunotherapy may be administered to reduce recurrence risk.
-
Cystectomy: Cystectomy is the surgical removal of the bladder.
- Partial Cystectomy: Removal of only a portion of the bladder, suitable in rare cases for select tumors.
- Radical Cystectomy: Removal of the entire bladder, along with surrounding lymph nodes and potentially nearby organs (prostate and seminal vesicles in men; uterus, ovaries, and part of the vagina in women). Radical cystectomy is often recommended for muscle-invasive bladder cancer.
Urinary Diversion
Following radical cystectomy, a new way to divert urine from the body is necessary. This is called urinary diversion.
- Ileal Conduit:
An ileal conduit is a form of urinary diversion where the surgeon creates a tube from a segment of the small intestine. This tube, known as the ileal conduit, is connected to the ureters, allowing urine to drain from the kidneys and exit the body through a stoma, an opening on the abdomen, into an external collection bag. This method is a straightforward and reliable option for urinary diversion after bladder removal.
- Neobladder Reconstruction:
Neobladder reconstruction is a complex surgical procedure performed after removing the bladder (cystectomy). In this procedure, a surgeon constructs a new bladder, or neobladder, from a section of the patient’s intestine. This neobladder is then connected to the urethra, aiming to restore a more natural way to urinate. While it offers the advantage of internal urine storage and voiding, it may not be suitable for all patients and can have potential complications such as incontinence or the need for intermittent catheterization.
- Continent Urinary Reservoir: The surgeon creates an internal pouch from a section of intestine to store urine. The patient drains this pouch by inserting a catheter through an abdominal opening several times a day.
Chemotherapy
Chemotherapy involves using drugs to destroy cancer cells. It can be administered in different ways for bladder cancer.
-
Intravesical Chemotherapy: Chemotherapy drugs are instilled directly into the bladder via a catheter. This is primarily used for non-muscle-invasive bladder cancer after TURBT to prevent recurrence.
-
Systemic Chemotherapy: Chemotherapy drugs are given intravenously or orally, circulating throughout the body to kill cancer cells. Systemic chemotherapy is used for muscle-invasive or metastatic bladder cancer, often before or after cystectomy, or as primary treatment when surgery is not an option.
Radiation Therapy
Radiation therapy uses high-energy beams to target and destroy cancer cells. It can be used as a primary treatment for bladder cancer, especially when surgery is not feasible or desired, or in combination with chemotherapy (chemoradiation).
Immunotherapy
Immunotherapy harnesses the body’s own immune system to fight cancer.
-
Intravesical Immunotherapy (BCG Therapy): Bacillus Calmette-Guerin (BCG), an immunotherapy agent, is instilled directly into the bladder after TURBT for high-risk non-muscle-invasive bladder cancer. BCG stimulates an immune response in the bladder to destroy cancer cells.
-
Systemic Immunotherapy: Intravenous immunotherapy drugs are used for advanced bladder cancer that has spread or recurred after initial treatment. These drugs, such as checkpoint inhibitors, help the immune system recognize and attack cancer cells throughout the body.
Targeted Therapy
Targeted therapy drugs specifically target vulnerabilities in cancer cells. These therapies may be considered for advanced bladder cancer when other treatments have been unsuccessful. Genetic testing of the tumor may be performed to identify if targeted therapy is likely to be effective.
Bladder Preservation
In select cases of muscle-invasive bladder cancer, a bladder preservation approach may be considered as an alternative to radical cystectomy. This trimodality therapy combines TURBT, chemotherapy, and radiation therapy to treat the cancer while preserving the bladder. Careful patient selection and close monitoring are crucial for this approach.
After Bladder Cancer Treatment: Follow-up Urology Care
Even after successful treatment, bladder cancer has a risk of recurrence. Therefore, ongoing follow-up care is essential. Regular cystoscopies and other tests are typically recommended to monitor for recurrence. The frequency of follow-up depends on the initial stage and grade of the cancer and the treatment received.
Coping and Support
Living with bladder cancer and the possibility of recurrence can be emotionally challenging. Seeking support is an important part of urology care and overall well-being. This may include:
- Scheduled Follow-up Appointments: Adhering to the recommended follow-up schedule and discussing any concerns with your urology team.
- Healthy Lifestyle: Maintaining a balanced diet, regular exercise, and adequate sleep to support overall health and resilience.
- Support Groups: Connecting with other bladder cancer survivors for emotional support and shared experiences.
Preparing for Your Urology Appointment
Being well-prepared for appointments with your urologist can help ensure you receive the most effective care. Consider the following:
- Pre-appointment Restrictions: Ask if there are any specific preparations needed before your appointment, such as dietary restrictions.
- Symptom List: Write down all symptoms you are experiencing, even if they seem unrelated.
- Medical History: Prepare key personal and medical information, including any significant stressors or recent life changes.
- Medication List: List all medications, vitamins, and supplements you are taking.
- Bring a Support Person: Consider bringing a family member or friend to help remember information and provide support.
- Questions to Ask: Prepare a list of questions to ask your doctor to make the most of your appointment time.
Questions to ask your urologist might include:
- What is the stage and grade of my bladder cancer?
- What are my treatment options and their potential risks and benefits?
- What is the goal of treatment in my case (cure, remission, or palliative care)?
- What are the potential side effects of treatment, and how will they be managed?
- What is the follow-up plan after treatment?
- Are there any clinical trials that I should consider?
- What resources are available for support and coping with bladder cancer?
By being informed and proactive, patients can partner effectively with their urology care team to navigate bladder cancer diagnosis, treatment, and long-term management, optimizing their health and quality of life.
References
- AskMayoExpert. Bladder cancer (adult). Mayo Clinic; 2018.
- Bladder cancer. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed April 1, 2020.
- Partin AW, et al., eds. Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed April 1, 2020.
- Bladder cancer treatment (PDQ). National Cancer Institute. https://www.cancer.gov/types/bladder/patient/bladder-treatment-pdq. Accessed April 8, 2020.
- What is retrograde pyelography? Urology Care Foundation. https://www.urologyhealth.org/urologic-conditions/retrograde-pyelography. Accessed April 15, 2020.
- AskMayoExpert. Urinary diversion. Mayo Clinic; 2019.
- Warner KJ. Allscripts EPSi. Mayo Clinic. Jan. 22, 2020.
